Login Register Cart 0
Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Exploring the Role of Nitric Oxide in Lower Airway Diseases: Insights and Real-world Application

Author(s): Pasquale Ambrosino*, Giuseppina Marcuccio and Mauro Maniscalco*

Volume 31, Issue 37, 2024

Published on: 10 January, 2024

Page: [6013 - 6017] Pages: 5

DOI: 10.2174/0109298673289734231228105444

conference banner
Next »
[1]
Sahebnasagh, A.; Saghafi, F.; Negintaji, S.; Hu, T.; Shabani-Borujeni, M.; Safdari, M.; Ghaleno, H.R.; Miao, L.; Qi, Y.; Wang, M.; Liao, P.; Sureda, A.; Simal-Gándara, J.; Nabavi, S.M.; Xiao, J. Nitric oxide and immune responses in cancer: Searching for new therapeutic strategies. Curr. Med. Chem., 2022, 29(9), 1561-1595.
[http://dx.doi.org/10.2174/0929867328666210707194543] [PMID: 34238142]
[2]
Ganster, R.W.; Taylor, B.S.; Shao, L.; Geller, D.A. Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-κB. Proc. Natl. Acad. Sci., 2001, 98(15), 8638-8643.
[http://dx.doi.org/10.1073/pnas.151239498] [PMID: 11438703]
[3]
Gustafsson, L.E.; Leone, A.M.; Persson, M.G.; Wiklund, N.P.; Moncada, S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem. Biophys. Res. Commun., 1991, 181(2), 852-857.
[http://dx.doi.org/10.1016/0006-291X(91)91268-H] [PMID: 1721811]
[4]
Clini, E.; Bianchi, L.; Foglio, K.; Porta, R.; Vitacca, M.; Ambrosino, N. Effect of pulmonary rehabilitation on exhaled nitric oxide in patients with chronic obstructive pulmonary disease. Thorax, 2001, 56(7), 519-523.
[http://dx.doi.org/10.1136/thx.56.7.519] [PMID: 11413349]
[5]
Dweik, R.A.; Boggs, P.B.; Erzurum, S.C.; Irvin, C.G.; Leigh, M.W.; Lundberg, J.O.; Olin, A.C.; Plummer, A.L.; Taylor, D.R. An official ATS clinical practice guideline: Interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am. J. Respir. Crit. Care Med., 2011, 184(5), 602-615.
[http://dx.doi.org/10.1164/rccm.9120-11ST] [PMID: 21885636]
[6]
Shapiro, A.J.; Davis, S.D.; Polineni, D.; Manion, M.; Rosenfeld, M.; Dell, S.D.; Chilvers, M.A.; Ferkol, T.W.; Zariwala, M.A.; Sagel, S.D.; Josephson, M.; Morgan, L.; Yilmaz, O.; Olivier, K.N.; Milla, C.; Pittman, J.E.; Daniels, M.L.A.; Jones, M.H.; Janahi, I.A.; Ware, S.M.; Daniel, S.J.; Cooper, M.L.; Nogee, L.M.; Anton, B.; Eastvold, T.; Ehrne, L.; Guadagno, E.; Knowles, M.R.; Leigh, M.W.; Lavergne, V. Diagnosis of primary ciliary dyskinesia. An official american thoracic society clinical practice guideline. Am. J. Respir. Crit. Care Med., 2018, 197(12), e24-e39.
[http://dx.doi.org/10.1164/rccm.201805-0819ST] [PMID: 29905515]
[7]
Ambrosino, P.; Motta, A.; Maniscalco, M. Nasal nitric oxide and chronic rhinosinusitis with nasal polyps: Is it a matter of inflammation or mechanical obstruction? Int. Forum Allergy Rhinol., 2023, 13(12), 2266-2267.
[http://dx.doi.org/10.1002/alr.23291] [PMID: 37846968]
[8]
Nucera, F.; Lo Bello, F.; Shen, S.S.; Ruggeri, P.; Coppolino, I.; Di Stefano, A.; Stellato, C.; Casolaro, V.; Hansbro, P.M.; Adcock, I.M.; Caramori, G. Role of atypical chemokines and chemokine receptors pathways in the pathogenesis of COPD. Curr. Med. Chem., 2021, 28(13), 2577-2653.
[http://dx.doi.org/10.2174/0929867327999200819145327] [PMID: 32819230]
[9]
Bhatt, S.P.; Rabe, K.F.; Hanania, N.A.; Vogelmeier, C.F.; Cole, J.; Bafadhel, M.; Christenson, S.A.; Papi, A.; Singh, D.; Laws, E.; Mannent, L.P.; Patel, N.; Staudinger, H.W.; Yancopoulos, G.D.; Mortensen, E.R.; Akinlade, B.; Maloney, J.; Lu, X.; Bauer, D.; Bansal, A.; Robinson, L.B.; Abdulai, R.M.; Investigators, B. Dupilumab for COPD with type 2 inflammation indicated by eosinophil counts. N. Engl. J. Med., 2023, 389(3), 205-214.
[http://dx.doi.org/10.1056/NEJMoa2303951] [PMID: 37272521]
[10]
Pavord, I.D.; Deniz, Y.; Corren, J.; Casale, T.B.; FitzGerald, J.M.; Izuhara, K.; Daizadeh, N.; Ortiz, B.; Johnson, R.R.; Harel, S.; Djandji, M.; Goga, L.; Crikelair, N.; Rowe, P.J.; Busse, W.W. Baseline FeNO independently predicts the dupilumab response in patients with moderate-to-severe asthma. J. Allergy Clin. Immunol. Pract., 2023, 11(4), 1213-1220.e2.
[http://dx.doi.org/10.1016/j.jaip.2022.11.043] [PMID: 36535524]
[11]
Hearn, A.P.; Kavanagh, J.; d’Ancona, G.; Roxas, C.; Green, L.; Thomson, L.; Fernandes, M.; Kent, B.D.; Dhariwal, J.; Nanzer, A.M.; Jackson, D.J. The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma. J. Allergy Clin. Immunol. Pract., 2021, 9(5), 2093-2096.e1.
[http://dx.doi.org/10.1016/j.jaip.2021.01.008] [PMID: 33486140]
[12]
Schumann, D.M.; Papakonstantinou, E.; Kostikas, K.; Grize, L.; Tamm, M.; Stolz, D. Variability of fractional exhaled nitric oxide is associated with the risk and aetiology of COPD exacerbations. Respirology, 2023, 28(5), 445-454.
[http://dx.doi.org/10.1111/resp.14439] [PMID: 36571108]
[13]
Annangi, S.; Nutalapati, S.; Sturgill, J.; Flenaugh, E.; Foreman, M. Eosinophilia and fractional exhaled nitric oxide levels in chronic obstructive lung disease. Thorax, 2022, 77(4), 351-356.
[http://dx.doi.org/10.1136/thoraxjnl-2020-214644] [PMID: 34417353]
[14]
Ambrosino, P.; Accardo, M.; Mosella, M.; Papa, A.; Fuschillo, S.; Spedicato, G.A.; Motta, A.; Maniscalco, M. Performance of fractional exhaled nitric oxide in predicting response to inhaled corticosteroids in chronic cough: A meta-analysis. Ann. Med., 2021, 53(1), 1659-1672.
[http://dx.doi.org/10.1080/07853890.2021.1979242] [PMID: 34528479]
[15]
Malerba, M.; Ragnoli, B.; Radaeli, A. Exhaled nitric oxide levels in alpha‐1‐antitrypsin PiMZ subjects. J. Intern. Med., 2009, 265(3), 382-387.
[http://dx.doi.org/10.1111/j.1365-2796.2008.02021.x] [PMID: 19019191]

Rights & Permissions Print Cite
Article Metrics
25
1
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy